Annual CFO
-$47.59 M
+$9.96 M+17.31%
31 December 2023
Summary:
Checkpoint Therapeutics annual cash flow from operations is currently -$47.59 million, with the most recent change of +$9.96 million (+17.31%) on 31 December 2023. During the last 3 years, it has fallen by -$31.04 million (-187.54%). CKPT annual CFO is now -4195.13% below its all-time high of -$1.11 million, reached on 31 December 2015.CKPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.21 M
-$4.97 M-79.65%
30 September 2024
Summary:
Checkpoint Therapeutics quarterly cash flow from operations is currently -$11.21 million, with the most recent change of -$4.97 million (-79.65%) on 30 September 2024. Over the past year, it has increased by +$3.54 million (+24.00%). CKPT quarterly CFO is now -574.89% below its all-time high of -$1.66 million, reached on 30 June 2016.CKPT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$30.76 M
+$3.54 M+10.32%
30 September 2024
Summary:
Checkpoint Therapeutics TTM cash flow from operations is currently -$30.76 million, with the most recent change of +$3.54 million (+10.32%) on 30 September 2024. Over the past year, it has increased by +$25.30 million (+45.13%). CKPT TTM CFO is now -1281.10% below its all-time high of -$2.23 million, reached on 31 March 2016.CKPT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CKPT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.3% | +24.0% | +45.1% |
| 3 y3 years | -187.5% | -73.5% | -41.3% |
| 5 y5 years | -84.4% | -221.6% | -26.8% |
CKPT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -187.5% | +17.3% | -79.7% | +42.8% | -41.3% | +46.6% |
| 5 y | 5 years | -187.5% | +17.3% | -418.7% | +42.8% | -106.2% | +46.6% |
| alltime | all time | -4195.1% | +17.3% | -574.9% | +42.8% | -1281.1% | +46.6% |
Checkpoint Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.21 M(+79.6%) | -$30.76 M(-10.3%) |
| June 2024 | - | -$6.24 M(-3.6%) | -$34.30 M(-14.3%) |
| Mar 2024 | - | -$6.47 M(-5.3%) | -$40.03 M(-15.9%) |
| Dec 2023 | -$47.59 M(-17.3%) | -$6.83 M(-53.7%) | -$47.59 M(-15.1%) |
| Sept 2023 | - | -$14.75 M(+23.2%) | -$56.06 M(+6.3%) |
| June 2023 | - | -$11.98 M(-14.6%) | -$52.72 M(+1.4%) |
| Mar 2023 | - | -$14.03 M(-8.3%) | -$51.98 M(-9.7%) |
| Dec 2022 | -$57.55 M(+118.8%) | -$15.30 M(+34.0%) | -$57.55 M(+11.3%) |
| Sept 2022 | - | -$11.42 M(+1.7%) | -$51.73 M(+10.6%) |
| June 2022 | - | -$11.23 M(-42.7%) | -$46.78 M(+13.4%) |
| Mar 2022 | - | -$19.61 M(+106.9%) | -$41.26 M(+56.8%) |
| Dec 2021 | -$26.31 M(+58.9%) | -$9.48 M(+46.7%) | -$26.31 M(+20.9%) |
| Sept 2021 | - | -$6.46 M(+13.2%) | -$21.76 M(+7.7%) |
| June 2021 | - | -$5.71 M(+22.6%) | -$20.21 M(+21.3%) |
| Mar 2021 | - | -$4.66 M(-5.6%) | -$16.67 M(+0.7%) |
| Dec 2020 | -$16.55 M | -$4.93 M(+0.4%) | -$16.55 M(+1.3%) |
| Sept 2020 | - | -$4.92 M(+127.5%) | -$16.35 M(+9.6%) |
| June 2020 | - | -$2.16 M(-52.4%) | -$14.92 M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$4.54 M(-4.0%) | -$17.71 M(-17.1%) |
| Dec 2019 | -$21.37 M(-17.2%) | -$4.73 M(+35.7%) | -$21.37 M(-11.9%) |
| Sept 2019 | - | -$3.49 M(-29.6%) | -$24.25 M(-10.9%) |
| June 2019 | - | -$4.96 M(-39.6%) | -$27.23 M(-5.5%) |
| Mar 2019 | - | -$8.20 M(+7.9%) | -$28.80 M(+11.6%) |
| Dec 2018 | -$25.80 M(+66.9%) | -$7.61 M(+17.7%) | -$25.80 M(+15.2%) |
| Sept 2018 | - | -$6.46 M(-1.1%) | -$22.39 M(+13.5%) |
| June 2018 | - | -$6.53 M(+25.4%) | -$19.74 M(+10.4%) |
| Mar 2018 | - | -$5.21 M(+24.2%) | -$17.88 M(+15.6%) |
| Dec 2017 | -$15.46 M(+55.4%) | -$4.19 M(+10.1%) | -$15.46 M(+0.2%) |
| Sept 2017 | - | -$3.81 M(-18.5%) | -$15.44 M(+14.1%) |
| June 2017 | - | -$4.67 M(+67.6%) | -$13.52 M(+28.7%) |
| Mar 2017 | - | -$2.79 M(-33.1%) | -$10.51 M(+5.6%) |
| Dec 2016 | -$9.95 M(+798.0%) | -$4.17 M(+120.1%) | -$9.95 M(+72.1%) |
| Sept 2016 | - | -$1.89 M(+14.0%) | -$5.78 M(+48.7%) |
| June 2016 | - | -$1.66 M(-25.4%) | -$3.89 M(+74.6%) |
| Mar 2016 | - | -$2.23 M | -$2.23 M |
| Dec 2015 | -$1.11 M | - | - |
FAQ
- What is Checkpoint Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics annual CFO year-on-year change?
- What is Checkpoint Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly CFO year-on-year change?
- What is Checkpoint Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics TTM CFO year-on-year change?
What is Checkpoint Therapeutics annual cash flow from operations?
The current annual CFO of CKPT is -$47.59 M
What is the all time high annual CFO for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual cash flow from operations is -$1.11 M
What is Checkpoint Therapeutics annual CFO year-on-year change?
Over the past year, CKPT annual cash flow from operations has changed by +$9.96 M (+17.31%)
What is Checkpoint Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CKPT is -$11.21 M
What is the all time high quarterly CFO for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly cash flow from operations is -$1.66 M
What is Checkpoint Therapeutics quarterly CFO year-on-year change?
Over the past year, CKPT quarterly cash flow from operations has changed by +$3.54 M (+24.00%)
What is Checkpoint Therapeutics TTM cash flow from operations?
The current TTM CFO of CKPT is -$30.76 M
What is the all time high TTM CFO for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high TTM cash flow from operations is -$2.23 M
What is Checkpoint Therapeutics TTM CFO year-on-year change?
Over the past year, CKPT TTM cash flow from operations has changed by +$25.30 M (+45.13%)